Clinical Trials
11 trialsNCT07579195 2026-05-14
Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial
University of Washington
Phase 1/2 Not yet recruiting
NCT04194554 2026-05-01
ASCLEPIuS
University of Michigan Rogel Cancer Center
Phase 1/2 Active not recruiting
NCT04536805 2025-12-08
REPAIR
Institut Cancerologie de l'Ouest
Phase 1/2 Recruiting
NCT03197571 2025-02-21
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
ImmunityBio, Inc.
Phase 1/2 Withdrawn
NCT02782715 2024-03-20
Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma
University of Wisconsin, Madison
Phase 1/2 Terminated
NCT00547339 2022-12-07
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
University of Texas Southwestern Medical Center
Phase 1/2 Completed
NCT02563691 2022-03-08
CROP
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown
NCT02581384 2021-04-30
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Dana-Farber Cancer Institute
Phase 1/2 Terminated
NCT04086290 2020-02-12
Oligomet_DK
Herlev Hospital
Phase 1/2 Recruiting
NCT00672178 2017-01-12
Stereotactic Body Radiotherapy (SBRT) and Sorafenib in Patients With Metastatic, Recurrent, or Unresectable Renal Cell Cancer (RCC)
Duke University
Phase 1/2 Terminated
NCT02334709 2017-01-11
Phase I/II Trial of Stereotactic Body Radiotherapy With Concurrent Fixed Dose Tyrosine Kinase Inhibitors in Metastatic Renal Cell Carcinoma: Dose Limiting Toxicity and Abscopal Effect.
University Hospital, Ghent
Phase 1/2 Completed